Desjardins Global Asset Management’s Medtronic MDT Stock Holding History

Desjardins Global Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.91M	Sell	23,232 -1,051	-4%	-$80.1K	0.21%	121
2023 Q3	$1.9M	Buy	24,283 +2,041	+9%	+$171K	0.21%	104
2023 Q2	$1.96M	Buy	22,242 +6,713	+43%	+$578K	0.23%	95
2023 Q1	$1.25M	Buy	15,529 +4,828	+45%	+$394K	0.16%	128
2022 Q4	$831K	Sell	10,701 -8,880	-45%	-$720K	0.13%	161
2022 Q3	$1.58M	Buy	19,581 +719	+4%	+$64.6K	0.2%	105
2022 Q2	$1.69M	Sell	18,862 -3,649	-16%	-$370K	0.22%	104
2022 Q1	$2.5M	Sell	22,511 -1,433	-6%	-$151K	0.22%	107
2021 Q4	$2.48M	Buy	+23,944	New	+$2.77M	0.21%	121

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Desjardins Global Asset Management's MDT Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its Medtronic (MDT) stake by 4.3% in Q4 2023, selling an estimated $80.1K and leaving 23,232 shares worth $1.91M. The position accounts for 0.21% of the portfolio, ranked #121.

Desjardins Global Asset Management first reported a position in MDT in Q4 2021 and has held it in 9 quarters since. The position peaked at $2.5M in Q1 2022. 2,074 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

Desjardins Global Asset Management held 23,232 shares of Medtronic worth $1.91M as of Q4 2023.
Desjardins Global Asset Management sold 1,051 Medtronic shares in Q4 2023, an estimated $80.1K.
Medtronic made up 0.21% of Desjardins Global Asset Management's portfolio in Q4 2023, its #121 holding.
Desjardins Global Asset Management first reported a position in Medtronic in Q4 2021 and has held it in 9 quarters since.
Desjardins Global Asset Management's Medtronic position peaked at $2.5M in Q1 2022.
2,074 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.